Caladrius Biosciences Inc is a pharmaceutical company based in New York, New York, specializing in the development of innovative therapies. Situated in the heart of Manhattan, the company focuses on advancing treatments that address critical medical needs. With its strategic location at 420 Lexington Avenue, Caladrius Biosciences operates in a dynamic environment conducive to collaboration within the biotech and pharmaceutical sectors.
The company’s work primarily involves research and development aimed at producing novel pharmaceutical products. By integrating scientific expertise and clinical insights, Caladrius Biosciences contributes to the broader healthcare industry through the exploration of new therapeutic modalities. Its efforts reflect the complex and rigorous processes inherent to pharmaceutical innovation, including preclinical studies and clinical trials.
Caladrius Biosciences maintains communication channels for professional inquiries and partnerships through its contact number, 908-842-0100. Although specific product pipelines and research areas are not detailed here, the company is part of the vibrant pharmaceutical landscape in New York, which supports advancements in drug discovery and development. This positioning enables it to engage with various stakeholders, including researchers, healthcare providers, and regulatory bodies, to bring potential therapies closer to patients.
Overall, Caladrius Biosciences Inc represents a focused pharmaceutical entity operating in one of the nation’s leading biotech hubs. Its presence in New York City underscores its commitment to contributing to medical science through pharmaceutical innovation, supporting the ongoing quest to improve patient outcomes.
